Viviana Murgia

Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

Sandro Pignata, Giovanni Scambia, Dionyssios Katsaros et al. · The Lancet Oncology · 2014 · 392 citations

Medicine, Gynecology, Oncology +12

Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: Correlation with stage and performance status

Giovanni Mantovani, Antonio Macciò, Clelia Madeddu et al. · International Journal of Cancer · 2001 · 154 citations

Life Sciences, Biochemistry, Oncology +16

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer

Alessandra Bearz, I. Garassino, Marcello Tiseo et al. · Lung Cancer · 2009 · 121 citations · Full text

Medicine, Oncology, Pharmacology +14

Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study

Marina Bagnoli, Silvana Canevari, Daniela Califano et al. · The Lancet Oncology · 2016 · 117 citations · Full text

Medicine, Bioinformatics, Oncology +16

The Impact of Different Antioxidant Agents alone or in Combination on Reactive Oxygen Species, Antioxidant Enzymes and Cytokines in a Series of Advanced Cancer Patients at Different Sites: Correlation with Disease Progression

Giovanni Mantovani, Antonio Macciò, Clelia Madeddu et al. · Free Radical Research · 2003 · 105 citations

Life Sciences, Oncology, Pharmacology +17